Taking biotech Start-ups to
the Next Level
CelCyr provides a clinical trial optimisation platform that uses AI-driven tools to improve patient selection and streamline enrolment.
We are particularly effective in clinical trials management and startup support in rare-disease patient populations and hard-to-recruit in Oncology, Immunology, Haematology and Neurology & Rehabilitation
We also empower startups growth by bringing together visionary leaders and astute angel investors to accelerate breakthroughs—achieving the extraordinary, ahead of expectations.
Grow Your Vision with AI
We are proud to be recognised among the top five global pioneers developing AI-dedicated platforms specifically designed to tackle the most complex and nuanced challenges of Phase I and II clinical trials, ranging from the most prevalent therapeutic areas to the rarest of diseases.
Navigating early-stage clinical development is often fraught with regulatory, scientific, and operational uncertainties. Our bespoke AI-powered platform, developed for you, is purpose-built to streamline this journey by enhancing patient stratification, expediting recruitment, monitoring safety and tolerability, validating biomarkers, and ensuring data integrity, all while maintaining full regulatory alignment.
Whether your innovation is impeded by clinical design complexity, translational hurdles, or manufacturing scale-up, our technology delivers intelligent, tailored solutions. By applying deep learning and predictive modelling, our statistical modelling and data engineering solutions will reduce preclinical and Phase I timelines from 3–4 years to as little as 9–12 months, accelerating your path to clinical success with confidence.
We Empower Your Growth
1. Sustainable technology for success
We are currently supporting early-stage companies engaged in a diverse range of discovery and research from advanced biomarker testing, real-time patient monitoring technologies, to AI-driven analytics designed to accelerate development timelines and enhance clinical trial enrolment outcomes.
2. Expertise in strategic management
Specialised knowledge and skills to navigate the unique challenges of building and scaling early-stage companies, including strategic planning, agile decision-making, resource optimisation & financial modelling, and leadership in fast-paced, uncertain environments.
3. Comprehensive Clinical Trial Support
Starting from preclinical / phase I studies you will have a dedicated experienced senior medical VP or Fractional CMO (as and when you need) to provide end-to-end solutions and support encompass protocol design, patient recruitment strategy, liaise with KOLS, carry out advisory boards, data management, and ensure regulatory compliance, all is tailored to meet the unique needs of your study.
4. Startup-Centric Approach
Our commitment to innovation and discovery and our startup-centric approach is focused on delivering agile, innovation-driven, and scalable solutions tailored to the unique needs of early-stage and growth-stage companies.
Analytics & Insights
-
Predictive site performance: our AI tools analyse site histories to predict enrollment rates, protocol adherence, and data quality.
-
Investigator matching: Matches trials with investigators with relevant experience, patient access, and performance metrics.
-
Retention prediction: Identify patients at risk of dropout using engagement and behavioural data
Product Development / go/no-go Strategic Decision
-
Futility analysis: AI models can simulate future trial outcomes to guide early termination or continuation decisions.
-
Portfolio optimisation: Evaluate how a candidate fits within the broader pipeline and competitor landscape.
-
Anomaly detection: Flag potential data entry errors, protocol deviations, or fraudulent data in real time.
Documentation Support
-
Scientific insight generation: Link compounds, targets, diseases, and outcomes using AI-curated knowledge graphs
-
Automated report generation: Draft clinical study reports (CSRs), investigator brochures, or regulatory summaries using NLP.
-
Protocol compliance checks: Validate trial protocols against evolving regulatory guidance and best practices
Our Executive Team
The Leadership team with an exceptional collective experience spanning 120 years, CelCyr consultants brings unparalleled expertise in clinical operations, Medical Affairs, regulatory roadmaps (EMA & FDA), followed by comprehensive product launch support, ensuring not only precision and innovation, but a deep commitment to advancing the future of your company. We win together.
DR Stephane ShekarSarai
Co-Founder &
C0-CEO
Stefano Juno
C0-CEO & CFO
Marcus Jacob
Nielsen
Co-Founder & COO
DR Eduardo Benso di Cavour
CMO
Share our future and join us
At CelCyr, we work at the intersection of biotech innovation and AI-driven research, advancing transformative solutions from discovery to early-phase clinical development.
While we can’t reveal all the details just yet, we're actively hiring for multiple confidential roles across the following areas:
- Clinical Research & Trial Operations
- Computational Biology & Bioinformatics
- AI/ML in Drug Discovery
- Data Science & Biostatistics
- Platform Engineering & DevOps
Please email your CV along with a brief but cover letter highlighting your experience, passion, and how you see yourself contributing to our CEO
Careers
